LITMIR.BIZ

LIST OF CONTRIBUTORS

      Jeffry Adiwidjaja, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia

      Lauren M. Aleksunes,Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA

      Suresh V. Ambudkar,Laboratory of Cell Biology, Transport Biochemistry Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

      Ebehiremen N. Ayewoh,Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA

      Agnes Basseville,Bioinformatics Unit, Institut de Cancérologie de l'Ouest, Saint Herblain, France

      Susan E. Bates,Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA

      Reina Bendayan,Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

      Rajinder K. Bhardwaj,Integrated Drug Development, Cetera Strategic Consulting, Parsippany, NJ, USA

      Kim L. R. Brouwer,Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

      Dina Buitrago,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA

      Stephen M. Carl,Department Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, West Lafayette, IN, USA; Discovery Pharmaceutics and Analytical Sciences, Bristol‐Myers Squibb Research Institute, Princeton, NJ, USA

      Cindy H. Chau,Genitourinary Malignancies Branch, Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

      Eugene C. Chen,Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA, USA

      Ayman El‐Kattan,DMPK, IFM Therapeutics, Boston, MA, USA

      Osatohanmwen Jessica Enogieru,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, CA, USA

      Melanie A. Felmlee,Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA, USA

      William D. Figg,Genitourinary Malignancies Branch, Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

      Azusa Futatsugi,Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

      Vadivel Ganapathy,Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Kathleen M. Giacomini,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA

      Rajgopal Govindarajan,Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA

      Jeffry C. Granados,Department of Bioengineering, University of California, San Diego, CA, USA

      Olafur Gudmundsson,Discovery Pharmaceutics and Analytical Sciences, Bristol‐Myers Squibb Research Institute, Princeton, NJ, USA

      Matthew D. Harwood,Simcyp Division, Certara UK Ltd., Sheffield, UK

      Dea Herrera‐Ruiz,Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, México

      Robert S. Jones,Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA, USA

      Melanie S. Joy,Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA

      Yukio Kato,Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

      Richard B. Kim,Departments of Medicine, Physiology & Pharmacology and Oncology, The University of Western Ontario, London, Ontario, Canada

      Franziska

Скачать книгу